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Background and Hypothesis 
     CF pulmonary exacerbations (PEx) are episodes of decline in respiratory function      that can 
be triggered by a variety of mechanisms, including respiratory viral infections.  The COVID-19 
pandemic resulted in school closures and home isolation policies      and      a potential reduction 
in exposure to other respiratory viruses.  The goal of this project is to study the impact of the 
COVID-19 pandemic on CF PEx at the Riley Hospital for Children     .  We hypothesize that the 
incidence of PEx will be lower during the period of the COVID-19 lockdown from March 1 to May 
15 in 2020 compared to the same time interval in 2019.   
 
Methods 
We performed a retrospective chart review of children with CF ages 2-12 (N=80) seen at Riley 
in 2019 and 2020 and collected data within the following timeframes: January 1 to March 15 
2019 and 2020, and March 16 to May 15 2019 and 2020.  We collected data on baseline clinical 
features and details of each PEx event.  Data were analyzed with      parametric and non-
parametric descriptive statistic tests as appropriate; significance was set at      P≤0.05     .  
 
Results 
     The percent of      PEx events in the study cohort was significantly lower in 2020 compared to 
2019 for January 1 to March 15 (56% vs 42%, P=0.0116) and March 16 to May 15 (35% vs 
14%, P<0.0001).  The percent of in-person PEx events was significantly lower during March 16 
to May 15 in 2020 compared to 2019 (15% vs 1%, P=0.0066) 
 
Conclusions and Potential Impact  
     COVID-19 restrictions were associated with a decrease PEx events.  We speculate that this 
reflects a reduced exposure to respiratory viral infections in general. The decrease in in-person 
PEx events may reflect a shift towards telehealth during the COVID-19 restrictions.  These 
results provide a foundation for further research into triggers and prevention of CF PEx.   
 
